This isn't going to squeeze anywhere. If you read what the FDA actually said about the application, you will see that drug is not going to get approval. When you invest in bio, you need to take your loss and move on. There are plenty of bio tech companies with incredible potential and multiple drugs in the pipeline that already show promise: for instance, CLDX. When investing in such companies, it is wise to look at how the successful ones grew: VRUS, AEGR, etc. SRPT does not have the characteristics those companies had, while CLDX does. I'm not in SRPT, but I have had my share of disasters. It is high risk high reward investing and there is nothing worse than turning a disaster into a long term dead money hold. Praying and hoping doesn't help. SRPT will be below 10 in the coming weeks and it won't recover anytime soon, if ever.